Sept. 26 (UPI) -- A Phase 3 clinical trial in India of the rotavirus vaccine BRV-PV known as ROTASIIL shows the vaccine is safe and effective against severe rotavirus.
Rotavirus is the most common and deadly cause of severe diarrhea with dehydration in infants and young children. In 2013, roughly 47,100 rotavirus deaths occurred in India with 22 percent of all rotavirus deaths occurring around the world. Rotavirus diarrhea represents the highest risk of dehydration, hospitalization and death.